Navigation Links
Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
Date:4/9/2013

rts information for multiple compounds per well from files or database systems
  • Fits mono-therapeutic Dose Response Curves
  • Calculates Synergy Scores using the Loewe and Highest Single Agent models
  • Visualizes combination effects in heat maps (e.g. for measured, modeled and excess activity)
  • New Applications for Single-Cell Analysis
    Genedata Screener 11 also features an enhanced Cell Population Extension for improved support of high throughput flow cytometry, cell cycle and similar experiments that define and display cell sub-populations. In a single view, researchers can define, manage, and display cell sub-populations and use cell sub-populations as input for cell-to-well data aggregation. These capabilities streamline processing of cell-based experiments and enable corporate-wide management of single-cell data, at an unprecedented scale.

    Collaboration in the Cloud
    Enabling new levels of collaborative research and screening data analysis, Genedata Screener 11 features advanced support for encrypted data transmission and authentication. Fully cloud-compliant, Genedata Screener 11 standardizes data analysis across different organizations and multiple sites. With the Genedata Screener server in the cloud, users run their clients in the local environment: while data transfer to and from the cloud is determined by the bandwidth of the network connection, Genedata Screener data processing speed and unique interactive capabilities persist.

    “Genedata Screener 11 will unleash new opportunities in lead optimization and target validation by giving pharmaceutical and biotechnology researchers a standardized platform on which they can efficiently visualize and explore compound combinations at unprecedented processing speed and with unsurpassed result quality,” said Dr. Othmar Pfannes, CEO of Genedata. “The ongoing innovation we are able to consistently deliver with each version of Genedata Scre
    '/>"/>

    Source: PRWeb
    Copyright©2012 Vocus, Inc.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
    2. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
    3. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
    4. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
    5. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
    6. Genedata Screener for HCS Advances Phenotypic Screening
    7. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
    8. Genedata Screener to Present at 10th Annual Ion Channel Retreat
    9. Transcreener Assays Highlighted for Challenging Microbial, Cancer and Epigenetic Drug Targets at SLAS 2013
    10. Risk Assessment and Mitigation in Phase I Trials in High Risk Compounds: A Continuously Developing Process, new life science webinar hosted by Xtalks
    11. Love triumphs over hate to make exotic new compound
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/2/2015)... 2, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... regenerative medicine, today announced that it will release fourth ... on Tuesday, March 10, 2015 after the close of ... conference call and webcast on Tuesday, March 10, 2015 ... discuss the results and recent corporate developments. ...
    (Date:3/2/2015)... 02, 2015 Global Stem ... alliance with Shenzhen HANK Bioengineering Co., Ltd. and ... alliance will establish a stem cells training course ... in September 2015. , Shenzhen HANK is a ... award-winning scientist, microbiologist and virologist, to integrate research, ...
    (Date:2/28/2015)... Increasing its efforts to resolve the GMO Controversy ... of The GMO TRUTH podcast on both ITunes and at ... its mission to discover the truth and change the world. ... the truth about the GMOs in our food supply,” adds ... is an expansion of the documentary/investigative film-making methodology in place ...
    (Date:2/27/2015)... , Feb. 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... toxicology studies for its newly developed Bruton,s tyrosine ... have been completed. The results of these preclinical ... and Drug Administration. The feedback received from the ... ongoing first-in-human study. Additional preclinical work is required ...
    Breaking Biology Technology:Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3
    ... Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical ... product candidates for central nervous system disorders, today announced ... March 31, 2009. Vanda reported a net loss ... compared to $7.5 million for the fourth quarter of ...
    ... Mass., April 29 LaVoie Group, a life ... has been selected as public relations agency of ... Inc. Donna L. LaVoie, President & CEO of ... Profectus during an important stage in the company,s ...
    ... billions in pest losses annually , ... St. Louis, MO (PRWEB) April ... Divergence, Inc. , has received more than $1.2 million in research grants, ... to further the company,s work on biotech traits for lesion nematode control ...
    Cached Biology Technology:Vanda Pharmaceuticals Reports First Quarter 2009 Results 2Vanda Pharmaceuticals Reports First Quarter 2009 Results 3Vanda Pharmaceuticals Reports First Quarter 2009 Results 4Vanda Pharmaceuticals Reports First Quarter 2009 Results 5Vanda Pharmaceuticals Reports First Quarter 2009 Results 6Vanda Pharmaceuticals Reports First Quarter 2009 Results 7Vanda Pharmaceuticals Reports First Quarter 2009 Results 8Vanda Pharmaceuticals Reports First Quarter 2009 Results 9Vanda Pharmaceuticals Reports First Quarter 2009 Results 10LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record 2Divergence Receives $1.2 Million in Grants, Including NSF Grant to Fund Continuing Nematode Research in Corn 2Divergence Receives $1.2 Million in Grants, Including NSF Grant to Fund Continuing Nematode Research in Corn 3
    (Date:2/5/2015)... , 5. Februar 2015 Marken ... Logistikunternehmen und hat eine neue Marketingkampagne gestartet, ... (Clinical Logistics Organization – CLO) der Branche ... lautet First , mit Schwerpunkt auf ... http://photos.prnewswire.com/prnh/20150205/173753 Logo - ...
    (Date:2/5/2015)... 26, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... http://www.nxt-id.com/ ) as part of its 2015 marketing and ... launched its new consumer website for Wocketwallet.com earlier this ... of NXT-ID said, "Our new corporate website naturally showcases ...
    (Date:2/5/2015)... Jan. 28, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... RedChip Global Online CEO Conference on January 29 th ... Gino Pereira , CEO of NXT-ID will present and ... the Wocket smart wallet and its full suite of ...
    Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
    ... has been discovered by a research group at the Sahlgrenska ... an insidious form of glandular cancer usually in the head ... discovery could lead to quicker and better diagnosis and more ... prestigious scientific journal Proceedings of the National Academy of ...
    ... animals and plants developed different genetic programs for cell ... one at the Swedish University of Agricultural Sciences, has ... programmed cell death in plants and animals are actually ... The findings were published in Nature Cell Biology ...
    ... in electronics applications, Kansas State University engineers made a ... Berry is a K-State assistant professor of chemical engineering ... single atom thick and discovered just five years ago. ... electronics properties -- Berry and Kabeer Jasuja, a K-State ...
    Cached Biology News:New cancer gene discovered 2Cell death occurs in the same way in plants, animals and humans 224-carat gold 'snowflakes' improve graphene's electrical properties 2
    St. Louis encephalitis Immunogen: St. Louis encephalitis. Storage: -20 C, Avoid Freeze/Thaw Cycles...
    Mouse Anti-Gemin2...
    5-bromo-2'-deoxyuridine (BrdU) Cell Biology Cell Proliferation Bromodeoxyuridine (BrdU) and Related Products...
    Rat CINC-2 alpha/beta Affinity Purified Polyclonal Ab...
    Biology Products: